Ironwood Pharmaceuticals

Listing Websites about Ironwood Pharmaceuticals

Filter Type:

Ironwood Pharmaceuticals

(7 days ago) Add photosOops! Something went wrong, please try again later.WebsiteDirectionsContact usOops! Something went wrong, please try again later.Suggest an edit · Your business? Claim nowHome - Ironwood Pharmaceuticalshttps://ironwoodpharma.comIronwood is a healthcare company dedicated to making a difference for people living with gastrointestinal (GI) diseases Ironwood Pharmaceuticals. Media Releases. November 22, …

Url: Visit Now

Category:  Pharmaceutical,  Health Detail Drugs


Ironwood Pharmaceuticals - Wikipedia

(4 days ago) Ironwood Pharmaceuticals, Inc is a publicly traded pharmaceutical company. It was originally called Microbia, Inc. Microbia was founded by postdocs from the lab of Gerald Fink at the …

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


Ironwood Pharmaceuticals, Inc. - Ironwood Pharmaceuticals …

(3 days ago) – Ironwood capitalizing on GI leadership and expertise in an effort to bring innovative therapies to patients – – Strategy centered on accelerating LINZESS ® (linaclotide) …

Url: Visit Now

Category:  Health Detail Drugs


Ironwood Pharmaceuticals Inc. Cl A - MarketWatch

(8 days ago) Ironwood Pharmaceuticals, Inc. is a healthcare company, which focuses on the development and commercialization of Gastrointestinal (GI) product opportunities in areas of significant …

Url: Visit Now

Category:  Pharmaceutical,  Health Detail Drugs


Ironwood Pharmaceuticals

(4 days ago) Welcome to the Ironwood Grants Management System. Ironwood believes that it is important to give back to the communities in which we work and have a corporate presence. We routinely …

Url: Visit Now

Category:  Health Detail Drugs


25,838 Shares in Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) …

(4 days ago) Ironwood Pharmaceuticals Stock Up 1.3 %. Shares of NASDAQ:IRWD opened at $11.73 on Monday. Ironwood Pharmaceuticals, Inc. has a 52-week low of $9.73 and a 52 …

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


Swiss National Bank Has $3.89 Million Stock Position in Ironwood

(5 days ago) Ironwood Pharmaceuticals, Inc. has a one year low of $9.73 and a one year high of $12.95. The company has a market capitalization of $1.80 billion, a PE ratio of 12.35 …

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


Ironwood Pharmaceuticals Medical Director Salary - Zippia

(5 days ago) The starting pay for a Medical Director at Ironwood Pharmaceuticals is $143,000 per year, or $69 an hour. How Much Does Ironwood Pharmaceuticals Pay Compared To …

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


Ironwood Pharmaceuticals, Inc. (IRWD) - Yahoo!

(6 days ago) Find the latest Ironwood Pharmaceuticals, Inc. (IRWD) stock quote, history, news and other vital information to help you with your stock trading and investing.

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


Ironwood Pharmaceuticals Reports Strong Third Quarter 2022 …

(3 days ago) Ironwood Pharmaceuticals (Nasdaq: IRWD), an S&P SmallCap 600® company, is a leading gastrointestinal (GI) healthcare company on a mission to advance the treatment of …

Url: Visit Now

Category:  Pharmaceutical,  Health Detail Drugs


Working at Ironwood Pharmaceuticals: 31 Reviews - Indeed

(9 days ago) Ironwood pharmaceuticals, started out as a really great company to work for. It was a small start up company with a single product. Senior leadership was great as well as management. …

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


Pharmaceutical Companies in North Bergen, NJ - Yellow Pages

(8 days ago) Fort Lee, NJ 07024. From Business: Based in Fort Lee, N.J., DAVA Pharmaceuticals Inc. is a global manufacturer and supplier of pharmaceutical products for the health care market. It …

Url: Visit Now

Category:  Pharmaceutical,  Health Detail Drugs


Enzon Pharmaceuticals, Inc, 20 Commerce Dr, Cranford, NJ, …

(3 days ago) Enzon Pharmaceuticals is a biopharmaceutical company dedicated to the development and commercialization of therapeutics to treat patients with cancer and other life-threatening …

Url: Visit Now

Category:  Pharmaceutical,  Cancer Detail Drugs


PolyGen Pharmaceuticals – Drug Product Development and …

(6 days ago) Polygen Pharmaceuticals Inc., based in Edgewood, New York, is a rapidly growing generic pharmaceutical company engaged in the licensing, development, marketing, sale and …

Url: Visit Now

Category:  Pharmaceutical Detail Drugs

Popular Searched

 › My medical mutual account

 › Baptist memorial hospital oxford ms my chart

 › What is frontline doctors

 › University of minnesota pharmacy requirements

 › Why is healthcare important to society

 › Hazardous drugs precautions current guidelines 2021

 › Is medicine worth it

 › Health insurance medical mutual

 › Teamsters supplemental insurance for medicare

 › Medical mutual medicare advantage formulary

Recently Searched

 › Providence primary care olympia wa

 › Monroe county tn medical society

 › Doctor who release date 2021

 › What are nomenclatures medical

 › Super easy healthy dinner

 › Doctors at valley medical center

 › Lancaster general hospital lancaster pa jobs

 › Kings pharmacy park slope

 › Nebraska medicaid preferred drug list 2021

 › Smart goals for medical billers

FAQ about Ironwood Pharmaceuticals

What is Ironwood Pharmaceuticals known for?

Ironwood Pharmaceuticals. Linaclotide (Linzess in the US and Mexico, and as Constella elsewhere), a drug used to treat irritable bowel syndrome with constipation and chronic constipation with no known cause, was approved in the US and Europe in 2012. Most of the marketing rights were licensed to Allergan and Astellas.

Will Ironwood Pharmaceuticals host an investor update call in 2021?

Ironwood Pharmaceuticals to Host Fourth Quarter and Full Year 2021 Investor Update Call

Why invest in Ironwood?

At Ironwood, we're focused on delivering differentiated medicines to patients and generating outstanding returns for shareholders. If we do this efficiently and effectively, we hope to inspire continued support so that we can seek to develop and deliver more medicines for patients living with GI diseases.

What happened to the anxiolytic that Ironwood abandoned?

BNC210 is an anxiolytic that Ironwood licensed and performed R&D on and then abandoned. In April 2018, the shares of Ironwood Pharmaceuticals closed up more than 10 percent on the news of biotech activist investor, Alex Denner joining its board.